Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-08-18

FDA Approved: RANOLAZINE — Supplemental Application (Lupin Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved Lupin Pharmaceuticals' supplemental application for ranolazine, enabling a generic version of the heart medicine to be marketed. This is a suppleme…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ranolazine (ranolazine)

Snippet

SUPPL AP for RANOLAZINE (RANOLAZINE)